2021 Q4 Form 10-K Financial Statement

#000175392622000356 Filed on March 29, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue
YoY Change
Cost Of Revenue -$130.0K -$130.0K
YoY Change -74.0% -126.0%
Gross Profit $130.0K $130.0K
YoY Change -74.0% -74.0%
Gross Profit Margin
Selling, General & Admin $777.0K $1.806M $6.693M
YoY Change -45.66% 36.82% -19.65%
% of Gross Profit 597.69% 5148.46%
Research & Development $644.0K $697.0K $2.370M
YoY Change 84.0% 148.93% -51.03%
% of Gross Profit 495.38% 1823.08%
Depreciation & Amortization $13.00K $18.00K $70.00K
YoY Change 30.0% -10.0% -57.32%
% of Gross Profit 10.0% 53.85%
Operating Expenses $1.421M $2.503M $9.063M
YoY Change -19.72% 56.44% -41.13%
Operating Profit -$1.291M -$2.503M -$8.933M
YoY Change 1.33% 56.24% -40.03%
Interest Expense $8.000K $2.000K $12.00K
YoY Change -140.0% -40.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.283M -$2.501M -$8.921M
YoY Change -0.54% 56.31% -40.05%
Income Tax
% Of Pretax Income
Net Earnings -$1.283M -$2.501M -$8.921M
YoY Change -0.62% 56.02% -40.05%
Net Earnings / Revenue
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$97.49K -$190.4K -$815.5K
COMMON SHARES
Basic Shares Outstanding 33.80K shares
Diluted Shares Outstanding 33.80K shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $69.59M $72.03M $69.59M
YoY Change 2088.46% 2851.97% 2088.46%
Cash & Equivalents $69.59M $72.03M $69.59M
Short-Term Investments
Other Short-Term Assets $914.0K $1.193M $914.0K
YoY Change -16.15% 37.13% -16.15%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $70.51M $73.22M $70.51M
YoY Change 1551.6% 2112.78% 1551.22%
LONG-TERM ASSETS
Property, Plant & Equipment $117.0K $387.0K $345.0K
YoY Change -32.76% 100.52% 102.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $27.00K $22.00K $27.00K
YoY Change 35.0% 10.0% 35.0%
Other Assets
YoY Change
Total Long-Term Assets $372.0K $409.0K $372.0K
YoY Change 94.76% 92.02% 95.79%
TOTAL ASSETS
Total Short-Term Assets $70.51M $73.22M $70.51M
Total Long-Term Assets $372.0K $409.0K $372.0K
Total Assets $70.88M $73.63M $70.88M
YoY Change 1489.22% 1990.57% 1489.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $519.0K $758.0K $519.0K
YoY Change 6.79% 165.96% 5.92%
Accrued Expenses $548.0K $2.826M $1.943M
YoY Change -37.37% 124.29% -7.91%
Deferred Revenue $335.0K
YoY Change 0.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $2.462M $3.919M $2.462M
YoY Change -52.03% 31.51% -52.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $52.00K $102.0K $52.00K
YoY Change
Total Long-Term Liabilities $52.00K $102.0K $52.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.462M $3.919M $2.462M
Total Long-Term Liabilities $52.00K $102.0K $52.00K
Total Liabilities $2.514M $4.021M $2.514M
YoY Change -51.01% 34.93% -50.99%
SHAREHOLDERS EQUITY
Retained Earnings -$328.6M
YoY Change 2.79%
Common Stock $347.9M
YoY Change 28.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $68.37M $69.61M $68.37M
YoY Change
Total Liabilities & Shareholders Equity $70.88M $73.63M $70.88M
YoY Change 1489.22% 1990.57% 1489.22%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income -$1.283M -$2.501M -$8.921M
YoY Change -0.62% 56.02% -40.05%
Depreciation, Depletion And Amortization $13.00K $18.00K $70.00K
YoY Change 30.0% -10.0% -57.32%
Cash From Operating Activities -$2.425M -$1.800M -$9.188M
YoY Change 67.24% 21.62% -45.38%
INVESTING ACTIVITIES
Capital Expenditures -$14.00K $0.00 -$14.00K
YoY Change -104.24%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$14.00K $0.00 -$14.00K
YoY Change -100.0% -120.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.000K 0.000 75.62M
YoY Change -99.91% 779.46%
NET CHANGE
Cash From Operating Activities -2.425M -1.800M -9.188M
Cash From Investing Activities -14.00K 0.000 -14.00K
Cash From Financing Activities 2.000K 0.000 75.62M
Net Change In Cash -2.437M -1.800M 66.41M
YoY Change -424.93% 66.67% -914.9%
FREE CASH FLOW
Cash From Operating Activities -$2.425M -$1.800M -$9.188M
Capital Expenditures -$14.00K $0.00 -$14.00K
Free Cash Flow -$2.411M -$1.800M -$9.174M
YoY Change 66.28% 21.62% -46.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
USD
CY2020 eyes Cashless Exercise Of Underwritters Warrants
CashlessExerciseOfUnderwrittersWarrants
USD
CY2020 eyes Stock Issued During Period Restricted Stock Award Gross
StockIssuedDuringPeriodRestrictedStockAwardGross
USD
CY2021 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
USD
CY2021 eyes Proceeds From Sale Of Assets Held For Sale
ProceedsFromSaleOfAssetsHeldForSale
USD
CY2021 eyes Repurchase Of Espp Shares And Fractional Shares In Connection With Reverse Stock Split
RepurchaseOfESPPSharesAndFractionalSharesInConnectionWithReverseStockSplit
USD
CY2020 eyes Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021 eyes Fair Value Of Warrants Issued In Connection With Issuance Of Common Stock
FairValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock
USD
CY2021 eyes Manufacture Warranty Period
ManufactureWarrantyPeriod
P3Y
CY2018 eyes Grant Received Funding Period
GrantReceivedFundingPeriod
P5Y
CY2021 eyes Grants Against Operating Expenses
GrantsAgainstOperatingExpenses
1400000 USD
CY2020 eyes Grants Against Operating Expenses
GrantsAgainstOperatingExpenses
1300000 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y0M7D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
shares
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2021 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
USD
CY2020 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
USD
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
USD
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
USD
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
USD

Files In Submission

Name View Source Status
0001753926-22-000356-index-headers.html Edgar Link pending
0001753926-22-000356-index.html Edgar Link pending
0001753926-22-000356.txt Edgar Link pending
0001753926-22-000356-xbrl.zip Edgar Link pending
eyes-20211231.xsd Edgar Link pending
eyes-20211231_cal.xml Edgar Link unprocessable
eyes-20211231_def.xml Edgar Link unprocessable
eyes-20211231_lab.xml Edgar Link unprocessable
eyes-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g082651_10k.htm Edgar Link pending
g082651_10k_htm.xml Edgar Link completed
g082651_ex23-1.htm Edgar Link pending
g082651_ex23-2.htm Edgar Link pending
g082651_ex31-1.htm Edgar Link pending
g082651_ex31-2.htm Edgar Link pending
g082651_ex32-1.htm Edgar Link pending
img001_v8.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending